Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-073519
Filing Date
2022-06-22
Accepted
2022-06-22 16:21:34
Documents
1
Period of Report
2022-06-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2218972-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2218972-3_4seq1.xml 4 4006
  Complete submission text file 0001104659-22-073519.txt   5367
Mailing Address C/O AMPHASTAR PHARMACEUTICALS, INC. 11570 6TH STREET RANCHO CUCAMONGA CA 91730
Business Address
PETERS WILLIAM J (Reporting) CIK: 0001263136 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36509 | Film No.: 221032320

Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Issuer) CIK: 0001297184 (see all company filings)

EIN.: 330702205 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations